Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy

Heart Rhythm

Volumn 12, Issue 12, 2015, Pages 2368-2375

  Witt, Christoffer Tobias ^a   Kronborg, Mads Brix ^a   Nohr, Ellen Aagaard ^b   Mortensen, Peter Thomas ^a   Gerdes, Christian ^a   Nielsen, Jens Cosedis ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Atrial fibrillation; Atrial high rate episodes; Cardiac resynchronization therapy; Mortality; Thromboembolic event

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; APIXABAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DABIGATRAN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RIVAROXABAN; SPIRONOLACTONE; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; ATRIAL HIGH RATE EPISODE; BLEEDING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CHADS2 VASC SCORE; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DENMARK; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HAZARD RATIO; HEART ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PACEMAKER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; THROMBOEMBOLISM; THROMBUS; COHORT ANALYSIS; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MIDDLE AGED; TIME FACTOR;

AGED; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; THROMBOEMBOLISM; TIME FACTORS;

EID: 84959261453     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.07.007     Document Type: Article

References (30)

1. A.S. Go, E.M. Hylek, K.A. Phillips, Y. Chang, L.E. Henault, J.V. Selby, and D.E. Singer Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 2001 2370 2375
2. M. Lamassa, A. Di Carlo, G. Pracucci, A.M. Basile, G. Trefoloni, P. Vanni, S. Spolveri, M.C. Baruffi, G. Landini, A. Ghetti, C.D. Wolfe, and D. Inzitari Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project) Stroke 32 2001 392 398
3. C.W. Israel, G. Gronefeld, J.R. Ehrlich, Y.G. Li, and S.H. Hohnloser Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device - implications for optimal patient care J Am Coll Cardiol 43 2004 47 52
4. P.D. Ziegler, J.L. Koehler, and R. Mehra Comparison of continuous versus intermittent monitoring of atrial arrhythmias Heart Rhythm 3 2006 1445 1452
5. G. Boriani, T.V. Glotzer, M. Santini, T.M. West, M. De Melis, M. Sepsi, M. Gasparini, T. Lewalter, J.A. Camm, and D.E. Singer Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices) Eur Heart J 35 2014 508 516
6. J.S. Healey, S.J. Connolly, M.R. Gold, and et al. Subclinical atrial fibrillation and the risk of stroke N Engl J Med 366 2012 120 129
7. Z. Binici, T. Intzilakis, O.W. Nielsen, L. Kober, and A. Sajadieh Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke Circulation 121 2010 1904 1911
8. T.V. Glotzer, E.G. Daoud, D.G. Wyse, D.E. Singer, M.D. Ezekowitz, C. Hilker, C. Miller, D. Qi, and P.D. Ziegler The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study Circ Arrhythm Electrophysiol 2 2009 474 480
9. M. Gonzalez, R.J. Keating, S.M. Markowitz, C.F. Liu, G. Thomas, J.E. Ip, B.B. Lerman, and J.W. Cheung Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers Heart Rhythm 11 2014 2214 2221
10. T.J. Bunch, J.D. Day, B. Olshansky, K.Q. Stolen, and C.M. Mullin INTRINSIC RV Study Investigators. Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality Heart Rhythm 6 2009 2 8
11. T.J. Wang, M.G. Larson, D. Levy, R.S. Vasan, E.P. Leip, P.A. Wolf, R.B. D'Agostino, J.M. Murabito, W.B. Kannel, and E.J. Benjamin Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study Circulation 107 2003 2920 2925
12. J.J. McMurray, S. Adamopoulos, S.D. Anker, and et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
13. N. Shanmugam, A. Boerdlein, J. Proff, P. Ong, O. Valencia, S.K. Maier, W.R. Bauer, V. Paul, and S. Sack Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population Europace 14 2012 230 237
14. F.H. Verbrugge, P. Nijst, H. Van Herendael, P. De Vusser, L. Jacobs, J. Vercammen, D. Verhaert, P. Vandervoort, M. Dupont, W. Mullens, and M. Rivero-Ayerza Asymptomatic episodes of device-registered atrial tachyarrhythmia are not associated with worse cardiac resynchronization therapy response Europace 16 2014 1197 1204
15. H.W. Kildemoes, H.T. Sorensen, and J. Hallas The Danish National Prescription Registry Scand J Public Health 39 2011 38 41
16. E. Lynge, J.L. Sandegaard, and M. Rebolj The Danish National Patient Register Scand J Public Health 39 2011 30 33
17. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation Chest 137 2010 263 272
18. R. Pisters, D.A. Lane, R. Nieuwlaat, C.B. de Vos, H.J. Crijns, and G.Y. Lip A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 2010 1093 1100
19. H.J. Crijns, G. Tjeerdsma, P.J. de Kam, F. Boomsma, I.C. van Gelder, M.P. van den Berg, and D.J. van Veldhuisen Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure Eur Heart J 21 2000 1238 1245
20. M. Pozzoli, G. Cioffi, E. Traversi, G.D. Pinna, F. Cobelli, and L. Tavazzi Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm J Am Coll Cardiol 32 1998 197 204
21. A.J. Camm, G.Y. Lip, R. De Caterina, I. Savelieva, D. Atar, S.H. Hohnloser, G. Hindricks, and P. Kirchhof ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 2012 2719 2747
22. E.G. Daoud, T.V. Glotzer, D.G. Wyse, M.D. Ezekowitz, C. Hilker, J. Koehler, and P.D. Ziegler TRENDS Investigators. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS Heart Rhythm 8 2011 1416 1423
23. M. Brambatti, S.J. Connolly, M.R. Gold, and et al. Temporal relationship between subclinical atrial fibrillation and embolic events Circulation 129 2014 2094 2099
24. T. Watson, E. Shantsila, and G.Y. Lip Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited Lancet 373 2009 155 166
25. D.T. Martin, M.M. Bersohn, A.L. Waldo, M.S. Wathen, W.K. Choucair, G.Y. Lip, J. Ip, R. Holcomb, J.G. Akar, and J.L. Halperin IMPACT Investigators. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices Eur Heart J 36 2015 1660 1668
26. C.J. Borleffs, C. Ypenburg, R.J. van Bommel, V. Delgado, L. van Erven, M.J. Schalij, and J.J. Bax Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy Heart Rhythm 6 2009 305 310
27. E.S. Kaufman, C.W. Israel, G.M. Nair, and et al. Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT Heart Rhythm 9 2012 1241 1246
28. T.A. Rix, S. Riahi, K. Overvad, S. Lundbye-Christensen, E.B. Schmidt, and A.M. Joensen Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry Scand Cardiovasc J 46 2012 149 153
29. L.H. Krarup, G. Boysen, H. Janjua, E. Prescott, and T. Truelsen Validity of stroke diagnoses in a National Register of Patients Neuroepidemiology 28 2007 150 154
30. M.T. Severinsen, S.R. Kristensen, K. Overvad, C. Dethlefsen, A. Tjonneland, and S.P. Johnsen Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution J Clin Epidemiol 63 2010 223 228